Aug 18, 2026 07:33AM
Aug 18, 2026 03:00AM
Jun 25, 2026 06:48AM
Jun 25, 2026 03:00AM
Jun 24, 2026 09:45AM
Jun 24, 2026 09:37AM
May 18, 2026 08:34AM The Biology Came First.
May 7, 2026 01:00AM
Apr 19, 2026 10:00AM
Dec 22, 2025 07:06AM
Oct 24, 2025 08:29AM
Aug 26, 2025 05:26AM
Aug 25, 2025 04:30PM
Aug 25, 2025 02:15AM RBC Capital Starts argenx SE (ARGX) at Outperform
Jul 6, 2025 10:00AM
Jun 30, 2025 04:13PM
Jun 30, 2025 11:40AM
Apr 11, 2025 09:44AM
Apr 11, 2025 07:08AM
Apr 11, 2025 06:36AM
Apr 11, 2025 06:29AM Guggenheim Reiterates Buy Rating on argenx SE (ARGX)
Apr 10, 2025 06:02PM
Apr 10, 2025 05:47PM
Jan 4, 2025 04:00PM
Jan 2, 2025 12:51PM
Nov 22, 2024 11:07AM
Oct 15, 2024 01:00AM
Sep 19, 2024 01:00AM argenx Announces Publication in The Lancet Neurology of Pivotal ADHERE Study Data in Chronic Inflammatory Demyelinating Polyneuropathy
Jul 29, 2024 06:55AM
Jul 26, 2024 06:47AM
Jul 16, 2024 12:15AM
Jun 24, 2024 06:58AM
Jun 24, 2024 06:35AM
Jun 21, 2024 04:52PM
Jun 21, 2024 04:50PM argenx Announces FDA Approval of VYVGART Hytrulo for Chronic Inflammatory Demyelinating Polyneuropathy
Apr 16, 2024 01:00AM
Mar 27, 2024 02:00AM
Feb 20, 2024 03:10AM
Feb 20, 2024 01:00AM
Jan 8, 2024 05:32AM
Jan 8, 2024 01:00AM
Jun 30, 2023 09:39AM argenx (ARGX) and Zai Lab (ZLAB) Announce FDA Approval of VYVGART
Jun 20, 2023 06:13PM
Jun 20, 2023 06:12PM
Apr 18, 2023 01:00AM
Mar 2, 2023 01:00AM
Jan 27, 2023 01:00AM
Dec 10, 2022 11:30AM
Nov 30, 2022 06:20AM argenx (ARGX) to Acquire Priority Review Voucher from FDA for $102M
Nov 30, 2022 01:00AM

329,909 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All